Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients
Open Access
- 2 May 2006
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 62 (2), 200-209
- https://doi.org/10.1111/j.1365-2125.2006.02637.x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The distribution and gender difference of CYP3A activity in Chinese subjectsBritish Journal of Clinical Pharmacology, 2003
- Interactions among Drugs for HIV and Opportunistic InfectionsNew England Journal of Medicine, 2001
- The Erythromycin Breath Test For the Prediction of Drug ClearanceClinical Pharmacokinetics, 2001
- Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV InfectionClinical Pharmacokinetics, 1999
- Effect of Multiple Doses of Rifampin on the [14C N‐methyl] Erythromycin Breath Test in Healthy Male VolunteersThe Journal of Clinical Pharmacology, 1998
- Protease Inhibitors in Patients with HIV DiseaseClinical Pharmacokinetics, 1997
- Importance of T-cell-dependent inflammatory reactions in the decline of microsomal cytochrome P450 concentration in the livers of rats infected with Fasciola hepaticaInternational Journal for Parasitology, 1995
- Metabolism of Drugs by Cytochrome P450 3A IsoformsClinical Pharmacokinetics, 1995
- Factors involved in the down-regulation of cytochrome P450 during Listeria monocytogenes infectionInternational Journal of Immunopharmacology, 1994
- Liver glutathione and cytochrome P450 activity in experimental infectionCritical Care Medicine, 1991